Acute myeloid leukemia with mutated nucleophosmin 1: an immunogenic acute myeloid leukemia subtype and potential candidate for immune checkpoint inhibition

• Jochen Greiner,
• Susanne Hofmann,
• Michael Schmitt,
• Marlies Götz,
• Markus Wiesneth,
• Hubert Schrezenmeier,
• Donald Bunjes,
• Hartmut Döhner,
• Lars Bullinger

Affiliations

Jochen Greiner

Department of Internal Medicine III, University of Ulm, Ulm, Germany;Department of Internal Medicine, Diakonie Hospital Stuttgart, Ulm, Germany

Susanne Hofmann

Department of Internal Medicine III, University of Ulm, Ulm, Germany;Department of Internal Medicine V, University of Heidelberg, Ulm, Germany

Michael Schmitt

Department of Internal Medicine V, University of Heidelberg, Ulm, Germany

Marlies Götz

Department of Internal Medicine III, University of Ulm, Ulm, Germany

Markus Wiesneth

Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and Institute of Transfusion Medicine, Ulm, Germany

Hubert Schrezenmeier

Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and Institute of Transfusion Medicine, Ulm, Germany

Donald Bunjes

Department of Internal Medicine III, University of Ulm, Ulm, Germany

Hartmut Döhner

Department of Internal Medicine III, University of Ulm, Ulm, Germany

Lars Bullinger

Department of Internal Medicine III, University of Ulm, Ulm, Germany